Savient Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.05.18	Janssen to Present New Data in Urothelial, Hematologic and Prostate Cancers at ASCO 2018, Including Best of ASCO Selections (PR Newswire)
24.01.18	Commvault Announces Fiscal 2018 Third Quarter Financial Results (PR Newswire)
16.05.17	Barington/Hilco Acquisition Corp. Announces Election of Jeffrey Nuechterlein as Chairman of the Board to Focus on the Company's Announced Merger with Oomba, Inc. (PR Newswire)
14.03.17	Monteverde & Associates PC Files Class Action Lawsuit On Behalf of Shareholders of Seventy Seven Energy, Inc. in the Western District of Oklahoma (PR Newswire)
27.01.17	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Seventy Seven Energy Inc. - SVNT (PR Newswire)
13.12.16	Patterson-UTI Energy and Seventy Seven Energy Announce Agreement to Merge (PR Newswire)
11.12.13	Savient Pharma To Sell All Assets To Crealta Pharma In $120.4 Mln Deal (RTTNews)
10.12.13	Savient Pharma Enters Agreement On Use Of Cash Collateral - Quick Facts (RTTNews)
16.10.13	Savient Receives Court Approval Of Key "First Day" Motions (PR Newswire)
15.10.13	Pre-market Movers For Oct 15 (C, JNJ, KO, NFLX, SVNT, FLIR, DPZ) (RTTNews)
15.10.13	ATRS Hits A High, CNDO's TRUST Fails, KOOL Has Some Hot News, MNKD, PLX On Watch (RTTNews)
15.10.13	Savient Pharmaceuticals Commences Voluntary Chapter 11 Proceeding - Quick Facts (RTTNews)
14.08.13	Savient Pharmaceuticals Reports Second Quarter 2013 Financial Results (PR Newswire)
25.11.08	Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Savient Pharmaceuticals, Inc. (Businesswire)
28.07.08	Savient Pharmaceuticals to Hold Second Quarter Financial Results Conference Call on Thursday, August 7, 2008 (Businesswire)
07.05.08	Savient Pharmaceuticals Reports First Quarter 2008 Financial Results (Businesswire)
13.12.07	Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies (Businesswire)
11.12.06	Savient Pharmaceuticals Announces Modification of Temporary Restraining Order in Patent Infringement Lawsuit against Sandoz Pharmaceuticals and Upsher-Smith Laboratories (Businesswire)
04.12.06	Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories (Businesswire)
26.09.06	Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Barr Laboratories Inc. (Businesswire)
31.08.06	Savient Pharmaceuticals to Present at Roth Capital Partners 2006 Conference on September 6, 2006 (Businesswire)
08.08.06	Savient Pharmaceuticals Reports Second Quarter and First Half 2006 Financial Results; Operating Profits of $1.9 Million for The Quarter (Businesswire)
06.07.06	Savient Appoints Chief Financial Officer and Treasurer (Businesswire)
22.06.06	Savient's Puricase(R) (PEG-uricase) Phase 2 Results Show Powerful Anti-hyperuricemic Activity in Treatment-Failure Gout Patients (Businesswire)
25.05.06	Savient Pharmaceuticals, Inc. Announces Results of Annual Meeting of Stockholders (Businesswire)
11.05.06	Savient Reports Results for First Quarter 2006 (Businesswire)
03.05.06	Savient Receives FDA Final Approval for Puricase (PEG-uricase) Phase 3 Special Protocol Assessment (SPA); Patient Dosing to Begin in May (Businesswire)
21.03.06	Savient and FDA Agree on Phase 3 Protocol SPA; Puricase(R) (PEG-uricase) on Track to Enter Phase 3 (Businesswire)
12.05.05	Savient Pharmaceuticals Reports Positive Top-Line Results for Puricase (Businesswire)
10.05.05	Savient Pharmaceuticals Reports Unaudited Results for First Quarter 20 (Businesswire)
30.03.05	Savient Strengthens Senior Management Team (Businesswire)
23.03.05	Savient Pharmaceuticals Enters Co-Promotion Agreement with Ferring for (Businesswire)
23.03.05	Savient Pharmaceuticals to Sell Global Biologics Manufacturing Busines (Businesswire)
11.02.05	Savient and Teva Launch TEV-TROPIN for Pediatric Growth Hormone Defici (Businesswire)
10.01.05	Savient Pharmaceuticals, Inc. Completes Patient Dosing in Phase 2 Clin (Businesswire)
06.01.05	Savient Pharmaceuticals, Inc. Submits New Drug Application for Soltamo (Businesswire)
06.01.05	Savient Pharmaceuticals, Inc. Announces an Exclusive Marketing Collabo (Businesswire)
06.01.05	Savient Pharmaceuticals, Inc. Corrects Method of Recognizing Revenue f (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’406.50	1.48 %	K V
Swiss Life Hldg	764.20	1.16 %	K V
Kuehne+Nagel Int	203.80	1.14 %	K V
Logitech Intl	91.02	0.91 %	K V
ABB	50.08	0.81 %	K V
Nestle	77.36	-0.18 %	K V
Swisscom	526.00	-0.19 %	K V
UBS Group	30.31	-0.36 %	K V
Givaudan	3’828.00	-0.57 %	K V
Alcon	81.70	-0.73 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Savient Pharmaceuticals Inc.

Aktien Top/Flop

Meistgelesene Nachrichten